OCUL · Ocular Therapeutix, Inc · Executive Compensation
$6.96
-0.33 (-4.53%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$2.12B
Shares
219.62M
Volume · Oct 2
4.96M
Avg daily vol (3M)
2.73M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jason Robins | Chief Financial Officer | Appointed | 2026-06-12 |
| Jason Robins | interim Chief Financial Officer | Appointed | 2026-01-23 |
| Leslie J. Williams | Class II director | Appointed | 2025-06-11 |
| Richard L. Lindstrom, M.D. | Class II director | Appointed | 2025-06-11 |
| Seung Suh Hong, Ph.D. | Class II director | Appointed | 2025-06-11 |
| Donald Notman | Chief Operating Officer | Appointed | 2024-09-03 |
| Charles Warden | Class I director | Appointed | 2024-06-14 |
| Adrienne L. Graves, Ph.D. | Class I director | Appointed | 2024-06-14 |
| Rabia Gurses Ozden, M.D. | Chief Medical Officer | Resigned | 2024-04-18 |
| Nadia Waheed, M.D. | Chief Medical Officer | Appointed | 2024-04-18 |
| Antony C. Mattessich | director | Resigned | 2024-04-18 |
| Pravin U. Dugel, M.D. | President and Chief Executive Officer | Appointed | 2024-04-18 |
| Peter Kaiser | Medical Director | Appointed | 2024-02-22 |
| Sanjay Nayak | Chief Strategy Officer | Appointed | 2024-02-22 |
| Jeffrey S. Heier | Chief Scientific Officer | Appointed | 2024-02-22 |
| Jeffrey S. Heier | Board | Resigned | 2024-02-22 |
| Pravin U. Dugel | Class III director | Appointed | 2024-02-22 |
| Pravin U. Dugel | Executive Chairman | Appointed | 2024-02-22 |
| Adrienne L. Graves, Ph.D. | member of the Board | Appointed | 2023-07-12 |
| Merilee Raines | Class III director | Appointed | 2023-06-16 |
| Jeffrey S. Heier, M.D. | Class III director | Appointed | 2023-06-16 |